Overview
The primary purpose of registries has traditionally been to collect data to better understand long-term trends in specific populations. Data from registries hold great potential: they can help make clinical trials more efficient and less expensive and potentially bring new treatments to patients faster.
To achieve this potential, stakeholders can use CTTI’s recommendations for registry trials to assess, develop, and evaluate registries for the support of clinical research and help meet expectations for FDA review of new products.
Solutions
Search AllRecommendation Summary
Recommendations
Resources
Related Items
- Determining the Suitability of Registries for Embedding Clinical Trials in the United States: A Project of the Clinical Trials Transformation Initiative
- New CTTI Recommendations Provide Path for More Efficient Clinical Trials Using Clinical Registries
- CTTI Presents Recommendations from the Registry Trials Project
- Embedding Clinical Trials within Registries: How Feasible?
- A Brave New World: Registry-Based Clinical Trials
News
- CTTI Paper Discusses Suitability of Patient Registries for Embedded Clinical TrialsEmbedding clinical trials into patient registries can lead to high-quality, efficient prospective research. However, methods for assessing which registries are appropriate to serve as the platform for the conduct of ...